Healthcare Policy

The long-awaited Women’s Health Strategy has been published. Its call for evidence in 2021 amassed over 100,000 responses – one of the...

Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March...

Mental health has been on the margins of the European health debate for a long time. Yet, one in six people in the EU, or more than 84...

Nanomedicine is a complex and diverse term, encompassing the use of nanomaterials for the diagnosis, control, prevention, and...

The promise of innovative technologies is significant and is welcomed globally. The prospect of new therapies that could save and...

What should your pharma company talk about for the next twelve months?

It’s a question that many communications and public...

In 2017, former President of the European Commission Jean-Claude Juncker presented his White Paper on the Future of Europe:...

Many years in the making, the first CVDPREVENT audit report, published recently, gives a detailed snapshot of how those with...

With the recent performance of Cancer Waiting Times the worst on record, and predictions of thousands of ‘missing’ cancer patients...

One of the most exciting things about working in health policy is that you often end up learning a great deal about a very complex,...

The number of times those of us working in the Brussels bubble have heard about the “digitalisation” and/or “digital transformation”...